Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma

Running, not enrolling

Conditions studied: Metastatic Renal Cell Carcinoma

In brief

ODYSSEY RCC is a prospective, observational Phase IV study is to understand the cancer management and health-related quality of life in patients with mRCC in routine real-world clinical practice in the United States, including both community and academic treatment settings.

Key facts

Study ID

NCT04919122

Run by

Duke University

People needed

468

Starts

2022-04-01

Expected to finish

2026-12-31

Last updated by the study team

2026-08-05

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 19 or over at time of informed consent.
• Diagnosis of metastatic renal cell cancer (mRCC) with less than or equal to (≤) 3 months of first-line systemic therapy or less than or equal to (≤) 3 months of second-line systemic therapy for mRCC.
• Prior surgery and radiation therapy are permitted.
• Prior neoadjuvant and adjuvant therapy for non-metastatic renal cell carcinoma are permitted.
• Patients currently not on therapy and being observed are permitted.
• Evidence of signed and dated informed consent document indicating that the patient has been informed of all pertinent aspects of the study.
• Ability to comply with completion of PROs

You may not qualify if…

• Patients being treated for metastatic solid tumors other than mRCC are excluded. Non-cytotoxic oral agents for adjuvant or maintenance therapy of other cancers are permitted.
• Patients who are not intending to undergo follow up care at a study site within PCORnet

Where it is running

• State University of Iowa — Iowa City, Iowa, United States
• University of Kansas Medical Center — Kansas City, Kansas, United States
• Ochsner Clinic Foundation d/b/a Ochsner Health — New Orleans, Louisiana, United States
• The Johns Hopkins University — Baltimore, Maryland, United States
• The Regents of the University of Michigan — Ann Arbor, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• The University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
• Duke University — Durham, North Carolina, United States
• The Ohio State University — Columbus, Ohio, United States
• Geisinger Clinic — Danville, Pennsylvania, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• The University of Texas Southwestern Medical Center — Dallas, Texas, United States
• University of Utah — Salt Lake City, Utah, United States
• The Medical College of Wisconsin, Inc. — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.